课题基金 / 基金详情

Comprehensive analyses of therapeutic strategy against chronic active Epstein-Barr virus(EBV) infection

Comprehensive analyses of therapeutic strategy against chronic active Epstein-Barr virus(EBV) infection
慢性活动性EB病毒(EBV)感染治疗策略综合分析
批准号:
18591190
负责人:
WAKIGUCHI Hiroshi
金额:
$2.44万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

WAKIGUCHI Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的目的是通过利用显性阴性EBNA 1(DNE 1; Mal. Ther.,11(4):578 - 90,2005),其可以从细胞中根除EBV附加体。我们通过DNE 1转导制备了EBV阳性和阴性NK和T细胞系的同基因对,并比较了它们的恶性程度。同时,用多细胞因子测定系统全面评估这些细胞对中细胞基因表达的改变,从而阐明EBV在恶性转化中的作用。此外,我们通过使用3种EBV抗原的四聚体测定分析了EBV特异性细胞毒性T细胞(EBV-CTL),即,BRLF1、BMLF1和EBNA3。研究结果如下:1.腺病毒载体介导的DNE 1转导成功地根除了大多数自然EBV阳性T细胞和NK细胞淋巴瘤和上皮肿瘤中的EBV附加体, ...更多信息 r细胞株的生长情况。与亲本EBV阳性T细胞和NK细胞肿瘤相比,DNE 1诱导的EBV缺失的T细胞和NK细胞显示出对其恶性表型的显著抑制,例如倍增时间延长和锚定非依赖性生长潜力的丧失。在部分EBV缺失的T细胞和NK细胞中,病毒基因组的缺失也导致细胞死亡.与亲代EBV阳性T细胞和NK细胞肿瘤相比,EBV丢失的T细胞和NK细胞显示出一些细胞因子如白细胞介素-9的产生显著降低。这些结果表明,T细胞和NK细胞中的EBV依赖性恶性表型以及可能还在上皮细胞中的EBV依赖性恶性表型,如在B细胞淋巴瘤中,至少部分地与EBV依赖性恶性表型的上调相关(即,自分泌机制)和/或某些细胞因子的下调。我们正计划探索细胞因子基因控制的机制和对EBV肿瘤发生的特异性影响。少
英文摘要
The aim of this study was to identify the cellular genes associated with or responsible for the oncogenesisi of Epstein-Barr virus (EBV) in EBV-positive T, MC and epithelial tumor cells, by utilizing dominant-negative EBNA1 (DNE1; Mal. Ther., 11(4): 578-90, 2005)that can eradicate EBV episomes from cells. We prepared isogenic pairs of EBV-positive and -negative NK- and T-cell lines by DNE1 transduction and compared their malignant grade. Concomitantly alterations of cellular gene expression in those cell pairs were comprehensively assessed with the multi-cytokine assay system, thereby elucidating the role(s)of EBV in malignant conversion. Further, we analysed EBV-specific cytotoxic T-cells (EBV-CTL) by a tetramer assay using 3 EBV-antigens, i.e., BRLF1, BMLF1 and EBNA3. The results obtained are as follows.1. Adenovirus vector-mediated transduction of our DNE1 successfully eradicated EBV episomes from the majority of naturally EBV-positive T-cell and NK-cell lymphoma and epithelial tumo … More r cell lines in a few days.2. The DNE1-induced EBV-lost T-cells and NK-cells showed a striking suppression of their malignant phenotypes, such as prolongation of doubling time and loss of anchorage-independent growth potential, compared with parental EBV-positive T-cell and NK-cell tumors. In a part of the EBV-lost T-cells and NK-cells, loss of viral genome also brought about cell death.3. The EBV-lost T-cells and NK-cells showed significantly decreased production of some cytokines, such as interleukin-9, compared with the parental EBV-positive T-cell and NK-cell tumors. Conversely, the production levels of another cytokine was also found to be upregulated in the EBV-lost T-cells.These results indicate that the EBV-dependent malignant phenotypes in T- and NK-cells and perhaps also in epithelial cells, as in B-cell lymphomas, are associated, at least partly, with upregulation (i.e., the autocrine mechanism) and/or down regulation of certain cytokines. We are planning to explore precisely the mechanisms of cytokine gene control and specific effects on EBV oncogenesis. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
小児腎移植におけるEBウイルス(EBV)モニタリング-EBV負荷量およびkillerT細胞の推移-
儿科肾移植中的 EB 病毒 (EBV) 监测 - EBV 载量和杀伤性 T 细胞的变化 -
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [佐藤, 哲也]
通讯作者: 哲也
小児腎移植におけるEBVモニタリング-EBV未感染レシピエントにおけるEBV負荷量とkillerT細胞推移の意義と限界
儿科肾移植中的 EBV 监测 - 未感染 EBV 的受者中 EBV 载量和杀伤性 T 细胞转变的意义和局限性
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [石原, 正行]
通讯作者: 正行
シンポジウム 3.EBウイルス感染症と皮膚 1)EBウイルス感染症-overview
研讨会 3. EB 病毒感染与皮肤 1) EB 病毒感染 - 概述
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [脇口, 宏, 脇口 宏]
通讯作者: 脇口 宏
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [藤枝 幹也, 前田 明彦, 脇口 宏, 今井 章介(翻訳)]
通讯作者: 今井 章介(翻訳)
共 47 条
    Study of pathogenesis of chronic active EB virus infection and its treatment strategy.
    • 批准号:
      22591182
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2010
    • 负责人:
      WAKIGUCHI Hiroshi
    • 依托单位:
    Studies on Pathogenesis of Chronic Active Epstein-Barr Virus Infection
    • 批准号:
      14570750
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.56万
    • 财政年份:
      2002
    • 负责人:
      WAKIGUCHI Hiroshi
    • 依托单位:
    海外基金